Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > BUSINESS
BUSINESS
- PDRadiopharma’s PET Imaging Agent Amyvid Widens Label Too
September 4, 2024
- Asahi Kasei Closes Tender Offer for Calliditas, Enriches Renal Franchise
September 4, 2024
- Stella Pharma, NCC, Sumitomo Heavy Industries Tie Up in BNCT Basket Trial
September 4, 2024
- Aculys Pharma Files Diazepam Nasal Spray in Japan
September 3, 2024
- PET Agent Vizamyl Approved for Use in Patients on Anti-Aβ Therapy
September 3, 2024
- Nichi-Iko to Finally Roll Out Halaven AG Nearly 4 Years after Approval
September 3, 2024
- Ex-Sanofi Exec John Pulvar Tapped as New CEO of Ferring Japan
September 3, 2024
- BMS Aspires to Double Japan Sales over Next Decade with 5 Growth Drivers
September 3, 2024
- RaQualia’s Acid Reducer Tegoprazan Approved in Colombia
September 3, 2024
- Janssen Offloads Nizoral Cream to Teikoku Seiyaku
September 3, 2024
- Susmed Seeks Partial Change of Approval for Insomnia App towards Coverage
September 3, 2024
- Mounjaro Wins Podium in July GP Rep Promotion Rankings: Intage
September 3, 2024
- Takeda Shooting for Rail Transport Ratio of 60% in Modal Shift Push
September 2, 2024
- Takeda Pushes Back Shipping Date as Trucker Overtime Cap Hits Logistics
September 2, 2024
- Gilead, Cancer Institute Hospital Form R&D Partnership
September 2, 2024
- Pfizer Japan Seeks Partial Change of Champix’s Approval towards Re-Supply
September 2, 2024
- Pfizer Rolls Out Prevenar 20 in Japan, Pediatric NIP Set to Start October
September 2, 2024
- Mochida, Meiji Expand Epadel Sales Collab to ASEAN, Taiwan
September 2, 2024
- Humira Filed for nr-axSpA in Japan Based on Public Knowledge: AbbVie
September 2, 2024
- UCB’s Anti-Epileptic Drug Briviact Now Available in Japan
September 2, 2024
